Search
27/05/2026
Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review
Portu, M, Sanz-Beltran, J, Borges, MAD, Navarro, J, Arias, A, Alvarez, P, Fernández-Rebollo, A, Reyes, C, Flores, J, Anguera, G, Maroto, P. Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review. Current Oncology. 2026; 33(6)DOI:10.3390/curroncol33060314. PMID:42346214. IF:3.400(Q2/4D).
26/05/2026
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2
Bolano-Diaz, CF, Verdu-Diaz, J, Hao, D, James, MK, Rufibach, L, Blamire, A, Reyngoudt, H, Carlier, PG, Gordish-Dressman, H, Hilsden, H, Spuler, S, Day, J, Jones, KJ, Bharucha-Goebel, D, Pestronk, A, Walter, MC, Paradas, C, Stojkovic, T, Mori-Yoshimura, M, Bravver, E, Pegoraro, E, Mendell, J, Straub, V, Diaz-Manera, J. Identification of prognostic biomarkers in a large cohort of patients with LGMD R2. JOURNAL OF NEUROLOGY. 2026; 273(6)DOI:10.1007/s00415-026-13868-0. PMID:42189263. IF:4.600(Q1/2D).
26/05/2026
Outcomes of Pneumonia in ICUs in Low- and Middle-Income Countries - A Systematic Review
Pitrowsky, M, Pacheco, MB, Ranzani, O, Amado, FS, Nassar, AP Jr, Besen, BAMP, Moralez, GM, Martins, G, Povoa, P, Silva, JRLE, Salluh, JIF. Outcomes of Pneumonia in ICUs in Low- and Middle-Income Countries - A Systematic Review. Nejm Evidence. 2026; 5(6)DOI:10.1056/EVIDoa2500244. PMID:42189048. IF:(Q/D).
25/05/2026
Percutaneous Annuloplasty Followed by TEER for Tricuspid Regurgitation A Multicenter Experience
Ruberti, A, Cepas-Guillén, P, Praz, F, Rudolph, V, Sanchez-Recalde, A, Vilalta, V, Papadis, A, Angellotti, D, Santaló-Corcoy, M, Sanchis, L, Freixa, X. Percutaneous Annuloplasty Followed by TEER for Tricuspid Regurgitation A Multicenter Experience. JACC-Cardiovascular Interventions. 2026; 19(10)DOI:10.1016/j.jcin.2026.02.022. PMID:42191324. IF:11.400(Q1/1D).
25/05/2026
Prompt Architecture as a High-Impact Design Factor in Expert-Rated Clinical Documentation Quality: A Controlled Comparative Study in Inpatient Rehabilitation
Eceizabarrena-Matxinandiarena, I, Frutos-Reoyo, EJ, Guerrero-Rojas, JI, Vidal-Millet, C, Tejada-Ezquerro, PI, Roldan-Arcelus, E, de Torres-García, I, Sanchez-Raya, J, Gil-Fraguas, L, Hernandez-Manada, M, Miguel-Benadiba, CD, Fierro, JMMI, Omeñaca, AT, Catta-Preta, MC, Teixeira-Taborda, A, Alvarez-Bandrés, N, Cutillas-Ruiz, R, Bascuñana-Ambrós, H. Prompt Architecture as a High-Impact Design Factor in Expert-Rated Clinical Documentation Quality: A Controlled Comparative Study in Inpatient Rehabilitation. Bioengineering-Basel. 2026; 13(6)DOI:10.3390/bioengineering13060617. PMID:42351862. IF:3.700(Q2/5D).
24/05/2026
Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial
Ortega-Paz, L, Laudani, C, Morr, CI, Sionis, A, Vidal-Cales, P, Arevalos, V, Andrea, R, De Diego, O, Ortega, E, Jimenez-Trinidad, FR, Dantas, AP, Angiolillo, DJ, Sabaté, M, Ortiz-Pérez, JT, Brugaletta, S. Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial. Journal of Clinical Medicine. 2026; 15(11)DOI:10.3390/jcm15114061. PMID:42278921. IF:2.900(Q1/2D).